Global Neurorehabilitation Device Market (2020 to 2028) – Featuring Bionik Laboratories, Tyromotion & Bioxtreme Among Others – ResearchAndMarkets.com

Global Neurorehabilitation Device Market (2020 to 2028) – Featuring Bionik Laboratories, Tyromotion & Bioxtreme Among Others – ResearchAndMarkets.com




Global Neurorehabilitation Device Market (2020 to 2028) – Featuring Bionik Laboratories, Tyromotion & Bioxtreme Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Neurorehabilitation Device Market 2019-2028” report has been added to ResearchAndMarkets.com’s offering.

The publisher, in its research report, estimates the global neurorehabilitation device market to proliferate with a CAGR of 14.52% in the forecast years 2019-2028.

The growing prevalence of neurological diseases is the major driving force behind the growth of this market. Further, the rise in the elderly population and the growing adoption of neurorehabilitation wearables & robotics are aiding this growth. In addition, technological advancements and the rising occurrence of neurological disorders in developing nations are creating major opportunities for growth. However, the lack of a skilled workforce to cater to people with neurological diseases and the high cost of treatment are hindering the market growth. In addition, stringent regulations by the government are creating hurdles in the path of growth.

Companies Mentioned

  • Bionik Laboratories Corp
  • Tyromotion Gmbh
  • Bioxtreme
  • Ectron Limited
  • Kinova
  • Abbott Laboratories
  • Biometrics Ltd
  • Reha Technology Ag
  • Medtronic Inc
  • Helius Medical Technologies
  • Hokoma Ag
  • Kinestica
  • Saebo
  • Neurostyle Pte Ltd
  • Ekso Bionics Holdings Inc

The global market for neurorehabilitation device spans across the regions of North America, the Asia-Pacific, Latin America, Europe, and the Middle East and Africa.

The Asia-Pacific region is expected to showcase the fastest growth rate in the global market in the forecast period. The APAC market is being driven mainly by the growth in the elderly population in the region. For instance, Japan has the highest number of older adults in the region. In addition, the government & private organizations are taking initiatives to spread awareness about neurological conditions. Further, they are also helping patients with such conditions to lead normal lives. The growing prevalence of neurological diseases, especially the older age group, is a major factor fueling market growth in the Asia-Pacific.

Key Topics Covered:

1. Global Neurorehabilitation Device Market – Summary

2. Industry Outlook

2.1. Market Definition

2.2. Porter’s Five Forces Model

2.3. Supply Chain Outlook

2.4. Impact of Coronavirus on Neurorehabilitation Device Market

2.5. Etymology of Neurorehabilitation Device

2.6. Key Impact Analysis

2.7. Market Attractiveness Index

2.8. Key Insights

2.9. Market Drivers

2.9.1. Rise in Geriatric Population

2.9.2. Growing Emergence of Neurorehabilitation Wearables and Robotics

2.9.3. Rising Prevalence of Neurological Diseases

2.10. Market Restraints

2.10.1. Lack of Skilled Workforce to Treat and Manage Neurological Diseases

2.10.2. High Cost of Treatment

2.11. Market Opportunities

2.11.1. Advancements in Technology

2.11.2. Rising Incidence of Neurological Disorders in Developing Economies

2.12. Market Challenges

2.12.1. Stringent Government Regulations

3. Neurehabilitation Device Market Outlook – by Product

3.1. Neuro-Robotic System

3.2. Brain-Computer Interface

3.3. Wearable Device

3.4. Non-Invasive Stimulator

3.5. Other Products

4. Neurehabilitation Device Market Outlook – by Application

4.1. Stroke

4.2. Cerebral Palsy

4.3. Parkinson’s Disease

4.4. Multiple Sclerosis

4.5. Other Applications

5. Neurehabilitation Device Market Outlook – by End-User

5.1. Hospital/Clinic

5.2. Research Institute

5.3. Cognitive Care Center

5.4. Other End-User

6. Neurehabilitation Device Market – Regional Outlook

6.1. North America

6.1.1. Market by Product

6.1.2. Market by Application

6.1.3. Market by End-User

6.1.4. Country Analysis

6.1.4.1. United States

6.1.4.2. Canada

6.2. Europe

6.2.1. Market by Product

6.2.2. Market by Application

6.2.3. Market by End-User

6.2.4. Country Analysis

6.2.4.1. Germany

6.2.4.2. France

6.2.4.3. United Kingdom

6.2.4.4. Italy

6.2.4.5. Russia

6.2.4.6. Spain

6.2.4.7. Rest of Europe

6.3. Asia-Pacific

6.3.1. Market by Product

6.3.2. Market by Application

6.3.3. Market by End-User

6.3.4. Country Analysis

6.3.4.1. China

6.3.4.2. Japan

6.3.4.3. Australia & New Zealand

6.3.4.4. India

6.3.4.5. South Korea

6.3.4.6. Asean Countries

6.3.4.7. Rest of APAC

6.4. Latin America

6.4.1. Market by Product

6.4.2. Market by Application

6.4.3. Market by End-User

6.4.4. Country Analysis

6.4.4.1. Mexico

6.4.4.2. Brazil

6.4.4.3. Rest of Latin America

6.5. Middle East and Africa

6.5.1. Market by Product

6.5.2. Market by Application

6.5.3. Market by End-User

6.5.4. Country Analysis

6.5.4.1. Saudi Arabia

6.5.4.2. United Arab Emirates

6.5.4.3. Turkey

6.5.4.4. South Africa

6.5.4.5. Rest of Middle East & Africa

7. Company Profiles

8. Research Methodology & Scope

For more information about this report visit https://www.researchandmarkets.com/r/coaswx

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900